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Ca2+ is an essential and ubiquitous second
messenger. Changes in cytosolic Ca2+ trigger events
critical for tumorigenesis, such as cellular motility,
proliferation, andapoptosis.Weshow that an isoform
of Secretory Pathway Ca2+-ATPase, SPCA2, is upre-
gulated in breast cancer-derived cells and human
breast tumors, and suppression of SPCA2 attenuates
basal Ca2+ levels and tumorigenicity. Contrary to
its conventional role in Golgi Ca2+ sequestration,
expression of SPCA2 increased Ca2+ influx by
a mechanism dependent on the store-operated
Ca2+ channel Orai1. Unexpectedly, SPCA2-Orai1
signaling was independent of ER Ca2+ stores or
STIM1 and STIM2 sensors and uncoupled fromCa2+-
ATPase activity of SPCA2. Binding of the SPCA2
amino terminus to Orai1 enabled access of its
carboxyl terminus to Orai1 and activation of Ca2+
influx. Our findings reveal a signaling pathway in
which the Orai1-SPCA2 complex elicits constitutive
store-independent Ca2+ signaling that promotes
tumorigenesis.
INTRODUCTION
Basal Ca2+ concentrations are tightly controlled within a narrow
submicromolar range by an array of Ca2+ channels and pumps
that are susceptible to dysregulation in cancer. Transient
changes in cytosolic Ca2+ induce downstream signaling events,
which regulate a wide range of cellular functions (Berridge et al.,
2003; Clapham, 2007; Roderick and Cook, 2008). Ca2+ signaling
is required for every stage of the eukaryotic cell cycle, including
activation and expression of transcriptional factors and cyclin-
dependent kinases that are necessary for cell-cycle progression
(Hogan et al., 2003; Roderick and Cook, 2008), as well as centro-
some duplication and separation (Fukasawa, 2007; Matsumoto84 Cell 143, 84–98, October 1, 2010 ª2010 Elsevier Inc.and Maller, 2002). Crosstalk with other signaling mechanisms,
such as the Ras pathway, regulates cell-cycle transition and
cell proliferation (Cook and Lockyer, 2006; Cullen and Lockyer,
2002). Dynamic regulation of Ca2+ signaling is achieved by coop-
eration of various cellular components including receptors,
channels, transporters, buffering proteins, and downstream
effectors (Berridge et al., 2003). Thus, inappropriate activation
of Ca2+ influx channels or downregulation of Ca2+ efflux
and sequestration mechanisms could increase basal Ca2+ to
augment Ca2+ signaling and tumor cell proliferation. Alterna-
tively, changes that deplete the endoplasmic reticulum (ER)
Ca2+ store can confer cellular resistance to apoptosis (Monteith
et al., 2007).
In most nonexcitable cells, depletion of ER stores elicits sus-
tained Ca2+ influx by store-operated Ca2+ (SOC) entry, defining
the major Ca2+ influx pathway. Upon the stimulation of cell-
surface receptors, depletion of ER Ca2+ results in release of
Ca2+ from lumenal EF hand domains of ER-localized STIM
proteins, triggering their translocation to ER-plasma membrane
junctions where they bind and activate Orai1, the pore subunit
of the Ca2+ release-activated Ca2+ (CRAC) channel, and result-
ing in refilling of ER stores (Cahalan et al., 2007; Gwack et al.,
2007; Lewis, 2007; Vig and Kinet, 2007). Store-operated Ca2+
influx is essential for maintaining ER Ca2+ content at a precise
level and functions in various physiological processes such
as gene transcription, cell-cycle progression, and apoptosis
(Parekh and Putney, 2005). Dysfunction of store-operated Ca2+
signalingmediated by STIM andOrai1 leads to inhibition of phys-
iological and pathophysiological activities including breast tumor
cell migration and tumor metastasis (Yang et al., 2009), vascular
smooth muscle cell proliferation and migration (Potier et al.,
2009), and T cell activation and tolerance (Oh-Hora et al., 2008).
The Secretory Pathway Ca2+-ATPases (SPCA) are ATP-pow-
ered pumps that deliver Ca2+ and Mn2+ ions into the Golgi lumen
for protein sorting, processing, and glycosylation (Durr et al.,
1998). In higher vertebrates, including human, this essential
function is carried out by the ubiquitously expressed SPCA1 iso-
form, with orthologs in lower eukaryotes including yeast, nema-
tode, and fruit fly (Missiaen et al., 2007). A closely related second
isoform, SPCA2, shares similar transport characteristics and
appears at first glance to have a redundant role, given its
absence in lower eukaryotes (Vanoevelen et al., 2005; Xiang
et al., 2005). The limited tissue distribution of SPCA2 includes
mammary epithelium, where it is sharply upregulated during
lactation. Whereas SPCA1 showed a modest 2-fold induction
upon lactation, SPCA2 increased by 35-fold and was localized
to the lumenal secretory cells of the mammary gland (Faddy
et al., 2008).
We hypothesized that transformation of mammary epithelial
cells to a cancerous phenotype would be accompanied by dys-
regulation of Ca2+ transporters and their downstream signaling
pathways, augmenting proliferation and tumor formation.
Furthermore, localized, inappropriate secretion of Ca2+ in the
absence of calcium buffers could result in microcalcifications
that appear as radiographic ‘‘signatures’’ on mammograms
used in diagnosis of breast cancer (Morgan et al., 2005).
Although microcalcifications have been extensively used to
characterize abnormalities in the breast tissue, a mechanistic
understanding of the source of calcium and the specific path-
ways that lead to their deposition has remained elusive.
In this study, we show that SPCA2 elicits constitutive Ca2+
signaling, mediated by Orai1, which correlates with oncogenic
activities of mammary tumor cells. Unexpectedly, SPCA2-
induced Ca2+ signaling was independent of its Ca2+ pump
activity, and not regulated by store depletion or STIM proteins.
SPCA2 interacted with Orai1 by its N terminus and activated
Ca2+ influx by the C terminus. These findings reveal a Ca2+
signaling mechanism in which Orai1 mediates store-indepen-
dent Ca2+ influx, and dysregulation of SPCA2 constitutively acti-
vates this pathway leading to oncogenic activity of tumor cells.
RESULTS
Upregulation of SPCA2 Induces Oncogenic Signaling
in Mammary Tumor Cells
We used quantitative RT-PCR to investigate the expression of
SPCA isoforms in a range of breast cancer-derived and nonma-
lignant mammary epithelial cells. In contrast to comparable
mRNA levels of SPCA1, SPCA2 was highly upregulated in
lumenal-like breast cancer-derived cell lines (Figure 1A). Exami-
nation of mRNA levels in breast tissue from a small pool of breast
cancer patients confirmed this upregulation (Figure 1B) and
prompted us to mine data from microarray profiles of 295
primary human breast tumors: highest levels of SPCA2 were
found in ERBB2+ tumors, among five transcriptional subtypes
(Figure S1 available online). Consistent with mRNA levels,
protein expression of SPCA2was higher inMCF-7 cells, a human
breast adenocarcinoma cell line, relative to MCF-10A, a nonma-
lignant humanmammary epithelial cell line; in contrast, therewas
no increase in SPCA1 expression in MCF-7 (Figure 1C). We used
lentiviral delivery of shRNA constructs to knock down expression
of endogenous SPCA proteins in MCF-7 cells (Figure 1D). Prolif-
eration was inhibited in SPCA2KD cells, with growth rates slower
than mock-transduced cells, and similar to cells growing in low
extracellular Ca2+ (0.1 mM). In contrast, SPCA1KD did not
cause this growth phenotype (Figure 1E). The RAS-RAF-MEK-
ERK1/2 pathway is known to play an essential role in cellproliferation and survival. Phosphorylation of ERK1/2 drives acti-
vation of transcriptional factors and expression of downstream
proteins such as cyclin D1, which is essential for completion of
the G1/S transition (Coleman et al., 2004; Roderick and Cook,
2008). Levels of phospho-ERK and cyclin D1 reduced dramati-
cally in SPCA2KD cells, as well as in cells incubated in low extra-
cellular Ca2+, relative to control cells (Figure 1F).
We examined the effects of depleting endogenous SPCA2 on
the transformed phenotype of MCF-7 cells by monitoring growth
of cells in soft agar. Fewer and smaller colonies were observed in
soft agar seeded with SPCA2KD cells compared to control cells,
and normalized results showed a clear reduction of growth
in SPCA2KD cells (Figure 1G). Conversely, overexpression of
SPCA2 in nontumorigenic MCF-10A cells conferred the ability
to form colonies in soft agar (Figure 1H) and increased prolifera-
tion rate (Figure 1I). We also monitored tumor generation in
nude mice injected subcutaneously in the flank with control
or SPCA2KD MCF-7 cells. We show that SPCA2KD conferred
only sporadic and delayed tumor formation relative to control
(Figure 1J).
To determine whether oncogenic activity of endogenous
SPCA2 was mediated by Ca2+ signaling, we measured basal
cytoplasmic Ca2+ levels in control MCF-7 and SPCA2KD cells.
We showed significant reduction of intracellular Ca2+ levels in
SPCA2KD cells and in cells growing in low extracellular Ca2+,
but not in SPCA1KD cells (Figure 1K). On the other hand, overex-
pression of SPCA2 in MCF-10A cells significantly increased
basal Ca2+ concentration (Figure 1L). Although basal Ca2+ levels
varied between cell lines, these levels could be modulated by
SPCA2 expression levels. Thus, SPCA2 appears to play a role
in regulating basal Ca2+, and upregulation of SPCA2 results in
constitutive increase of basal Ca2+ and cell proliferation associ-
ated with oncogenesis.
SPCA2 Elicits Constitutive Ca2+ Signaling Independent
of Transport Function
To investigate the molecular basis of SPCA2-induced Ca2+
signaling, we began by monitoring Ca2+-dependent localization
of the nuclear factor of activated T cells, NFAT (Crabtree and
Olson, 2002; Huang et al., 2006), in HEK293 cells where expres-
sion of SPCA2 is relatively low (Figure S2A). In resting cells, GFP-
tagged NFAT localized exclusively in the cytoplasm. Following
treatment with thapsigargin, a blocker of sarco/endoplasmic
reticulum Ca2+-ATPases (SERCA), depletion of ER Ca2+ resulted
in store-operated Ca2+ entry, elevation of basal Ca2+ level, and
nuclear translocation of NFAT-GFP in nearly 100% of cells, as
expected (Figures 2A and 2B). Whereas transient expression of
SPCA1 in HEK293 cells did not alter cytoplasmic localization
of NFAT-GFP under resting conditions, transient expression of
SPCA2 elicited nuclear translocation of NFAT-GFP in 75% of
cells. This was inhibited by store-operated Ca2+ channel
blockers, miconazole (Clementi and Meldolesi, 1996), and
2-APB (Parekh and Putney, 2005) at the reported concentra-
tions, and in low extracellular Ca2+, indicating Ca2+ entry through
plasma membrane Ca2+ channels. Inhibition of the Ca2+-acti-
vated Ser/Thr phosphatase calcineurin by FK506 also prevented
nuclear relocalization of NFAT-GFP in SPCA2-transfected cells
(Figures 2A and 2B). Accordingly, NFAT was predominantlyCell 143, 84–98, October 1, 2010 ª2010 Elsevier Inc. 85
Figure 1. Upregulation of SPCA2 Induces Oncogenic Signaling in Mammary Tumor Cells
mRNA levels weremeasured by quantitative real-time RT-PCRs and normalized to 18S rRNA in (A) a panel of breast epithelial cell lines relative to 184A1 and (B) in
human breast tumor samples compared to matched normal surrounding breast tissue. n = 3 in (A).
(C) Immunoblot of SPCA expression in MCF-10A and MCF-7 cells.
Immunoblot (D) and normalized proliferation (E) of MCF-7 cells lentivirally transduced with shRNA against SPCA isoforms are shown. n = 3 in (E).
(F) Immunoblot of ERK 1/2 phosphorylation and cyclin D1 expression in MCF-7 cells transduced with shSPCA2.
Micrographs and normalized growth of (G) MCF-7 cells with SPCA2 knockdown or (H) MCF-10A cells with SPCA2 overexpression in soft agar are shown; n = 3.
Immunoblot showing relative SPCA2 expression levels is shown in (H).
(I) Normalized proliferation of MCF-10 cells with SPCA2 overexpression; n = 3.
(J) Tumor incidence in nude mice injected with MCF-7 cells; n = 6, p = 0.005 (log-rank test).
(K) Basal Ca2+ levels in MCF-7 cells with SPCA2 knockdown. From left to right: n = 80, 80, 77, 81, 69. **p < 0.01 (Student’s t test).
(L) Basal Ca2+ levels in MCF-10A cells with SPCA2 overexpression. Vector, n = 23; SPCA2, n = 23. **p < 0.01 (Student’s t test).
Error bars represent standard error (K and L) or standard deviation (A, E, G, H, and I).
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Figure 2. SPCA2 Elicits Constitutive Ca2+ Signaling Independent of Transport Function
Representative live images (A) and quantification of nuclear localization (B) of NFAT-GFP in HEK293 cells transfected with SPCA1 or SPCA2, or treated with
drugs. n = 3 in (B).
(C) Immunoblot showing phosphorylation status of NFAT following expression of SPCA1or SPCA2 or treatment with thapsigargin (TG) or FK506.
(D) Alignments showing conserved aspartates in phosphorylation (P) domain (D379 in SPCA2) or transmembrane helix 6 (D772 in SPCA2) of P-type Ca2+-
ATPases.
(E) Immunoblot and normalized growth of yeast K616 expressing SPCA2 or mutants D379N and D772A in BAPTA medium; n = 4.
(F) Representative live images, quantification of NFAT translocation in HEK293 cells, and immunoblot showing expression of SPCA2 WT or mutants; n = 3.
(G) Basal Ca2+ levels in HEK293 cells expressing SPCA1, SPCA2, or D379A mutant. From left to right, n = 57, 47, 46, 44. **p < 0.01 (Student’s t test).
Error bars represent standard error (G) or standard deviation (B, E, and F).dephosphorylated in TG-treated- or SPCA2-expressing cells but
remained phosphorylated in cells transfected with SPCA1 or
empty vector and in FK506-treated cells (Figure 2C).
These findings were unexpected, given the known function
of SPCA2 in pumping Ca2+ away from the cytoplasm intoGolgi/vesicular stores. To determine whether constitutive Ca2+
signaling elicited by SPCA2 was dependent on its Ca2+ pumping
ability, we generated two variants: mutant D379N lacks the
conserved and essential aspartate that is transiently phosphory-
lated by ATP in the catalytic cycle, and mutant D772A disruptsCell 143, 84–98, October 1, 2010 ª2010 Elsevier Inc. 87
Figure 3. SPCA2-Mediated Ca2+ Signaling Is Store Independent
(A) Localization of YFP-STIM1 in HEK293 cells following TG treatment or SPCA2 expression.
(B) Representative Ca2+ traces following emptying of stores with 2 mM Ionomycin in HEK293 cells with or without SPCA2 expression. Vector, n = 40; SPCA2,
n = 25. Cells were cultured in low Ca2+medium (0.1 mM) after transfection, followed by a 30 min incubation in normal Ca2+ (2 mM) immediately before calcium
imaging experiments to allow restoration of stores (as described in Extended Experimental Procedures—Calcium imaging).
(C) Representative images of GFP-SPCA1 and NFAT-mCherry following TG treatment or SPCA2 expression in HEK293 cells and (D) quantification of nuclear
NFAT-mCherry translocation. n = 3 in (D).
(E) Quantification of NFAT nuclear translocation following STIM1 knockdown or expression of dominant-negative STIM1 mutant in cells treated with TG or
expressing SPCA2; n = 3.
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a conserved and essential Ca2+-binding site (Figure 2D) (Wei
et al., 2000). Both mutants failed to rescue growth of a yeast
strain lacking endogenousCa2+ pumps in BAPTA-supplemented
medium, consistent with loss of Ca2+-ATPase activity
(Figure 2E), but retained ability to elicit constitutive NFAT trans-
location in HEK293 cells (Figure 2F). Also, mutant D379N
induced growth of MCF-10A in soft agar similar to wild-type
(WT) SPCA2 (Figure S2B). Furthermore, introduction of SPCA2,
either WT or D379N mutant, resulted in elevated basal cyto-
plasmic Ca2+ levels in HEK293 cells, relative to cells transfected
with empty vector or SPCA1 (Figure 2G). This was reminiscent of
the effect of upregulation of endogenous SPCA2 on basal Ca2+
levels in MCF-7 cells (Figure 1K). We conclude that SPCA2,
but not SPCA1, induces constitutive Ca2+ influx and signaling
by a mechanism that is independent of its known function as
a Ca2+-ATPase.
SPCA2-Mediated Ca2+ Signaling Is Store Independent
To investigate the possibility that SPCA2 could elicit ER Ca2+
store depletion leading to constitutive store-operated Ca2+ entry
(SOCE), we examined the status of the ER Ca2+ store. YFP-
STIM1, the ER-localized Ca2+ sensor protein, was present in
a reticular, ER-like pattern in resting cells and redistributed to
punctae after store depletion with thapsigargin (Liou et al.,
2005), as expected (Figure 3A). Transient transfection with
SPCA2 did not elicit puncta formation of YFP-STIM1, suggesting
that the ER store was not Ca2+ depleted (Figure 3A). Next, we
directly measured the ER Ca2+ content by ionomycin treatment
to completely release Ca2+ from intracellular stores. In Ca2+-
free medium, peak levels of Ca2+ released by ionomycin were
identical in cells transfected with SPCA2 or empty vector
(Figure 3B and Figures S3A and S3B). In a different, independent
approach, we used a thapsigargin-insensitive, ER-localized
Ca2+-ATPase to ensure that intracellular ER stores were replete
with Ca2+. N-terminal GFP-tagged SPCA1 partially mislocalized
to the ER (Figure S3C) where it is functional in filling the stores
and preventing nuclear translocation of NFAT-mCherry after
thapsigargin treatment (Figure S3D and Figures 3C and 3D).
Despite coexpression with ER-localized GFP-SPCA1, SPCA2
was capable of eliciting nuclear translocation of NFAT-mCherry
(Figures 3C and 3D). HA-tagged SPCA1 localizes to the Golgi
(Figure S3C) and does not interfere with thapsigargin-induced
SOCE, nor with SPCA2-induced nuclear translocation of
NFAT-mCherry (Figure 3D), indicating that Ca2+ signaling by
SPCA2 is also independent of Golgi stores. It was previously
reported that knockdown of STIM1 or expression of the domi-
nant-negative mutant D76A DERM blocked SOC signaling
(Huang et al., 2006; Roos et al., 2005), as seen by the failure of
TG to elicit nuclear translocation of NFAT (Figure 3E and Figures
S3E and S3F). Also, knockdown of STIM2, the feedback regu-
lator of cytosolic and ER Ca2+ levels, was shown to lower basal
Ca2+ concentration (Brandman et al., 2007) (Figures S3E and(F) Initial rates of Ca2+ influx in HEK293 cells with or without SPCA2 expression,
2.0 mM extracellular Ca2+. Vector: n = 30 (0.5 mM), 25 (1.0 mM), 28 (2.0 mM); SP
Representative Ca2+ traces (G) and average intracellular Ca2+ concentration repr
ControlKD and SPCA2KD MCF-7 cells. ControlKD, n = 36; SPCA2KD, n = 30. *p <
Error bars represent standard error (B, F, G, H, and I) or standard deviation (D anS3G). However, despite expression of dominant-negative
D76A DERM or knockdown of STIM1 and STIM2 expression,
either singly or in combination, SPCA2 retained the ability to
increase basal Ca2+ concentration and cause NFAT-GFP trans-
location to the nucleus, evidently by a STIM-independent Ca2+
signaling mechanism (Figure 3E and Figures S3F and S3G).
We showed that SPCA2 expression in HEK293 cells resulted in
Ca2+ influx from the extracellular medium, as shown by Mn2+
quench of intracellular preloaded Fura-2 as well as 45Ca2+
uptake (Figures S4A and S4B). Initial rates of uptake, monitored
within the first 60 s, were significantly increased by expression of
SPCA2 (Figure 3F and Figures S4D–S4I). Additionally, measure-
ment of 45Ca2+ efflux and Fura2 fluorescence confirmed that
SPCA2-induced elevation of intracellular Ca2+ did not result
from decreased rates of Ca2+ efflux (Figures S4C–S4F). Consis-
tent with these findings, knockdown of endogenous SPCA2 in
MCF-7 cells also diminished store-independent Ca2+ entry
without changing internal Ca2+ stores (Figures 3G–3I). Taken
together, our results reveal a mechanism for SPCA2-mediated
Ca2+ signaling that is independent of both ER and Golgi Ca2+
stores.
SPCA2 Interacts with Orai1 to Mediate Ca2+ Entry
Our results suggested that SPCA2 elicited Ca2+ influx through
plasma membrane Ca2+ channels. Immunofluorescence and
cell-surface biotinylation showed partial localization of endoge-
nous SPCA2 to the plasma membrane in MCF-7 cells, where it
has the potential to elicit Ca2+ influx (Figures 4A and 4B). Next,
we sought evidence for physical interaction between SPCA2
and candidate Ca2+ channels. Although SPCA2-mediated Ca2+
influx was independent of ER stores, we observed coimmuno-
precipitation of the endogenous store-operated channel
Orai1 and native SPCA2 in MCF-7 cells (Figure 4C). We verified
and extended these findings using epitope-tagged proteins
expressed in HEK293 cells: we could document robust coimmu-
noprecipitation of Orai1-Myc and HA-SPCA2 (Figure 4D).
Consistent with the specificity of the Orai1-SPCA2 interaction,
HA-SPCA1 did not coimmunoprecipitate with Orai1 (Figure 4D).
Similar to endogenous protein, up to 10% of HA-SPCA2
could be labeled by cell-surface biotinylation, including both
WT and the pump-inactive D379N mutant; in contrast, SPCA1
was barely detectable (Figure 4E). Surface residence of SPCA2
correlated with total expression levels, and with elevation of
basal Ca2+ (Figure S5A). We also used cell-surface biotinylation
to confirm that a portion of SPCA2-complexed Orai1 was found
at the plasma membrane (Figures S5B and S5C). Although
SPCA2 preferentially interacted with lower molecular weight
bands of posttranslationally modifiedOrai1 as has been reported
for STIM1 (Park et al., 2009; Vig et al., 2006), we confirmed that
all forms of Orai1 reached the plasma membrane where they
could be biotinylated (Figure 4B). Epitope-tagged SPCA2 and
Orai1 also partially colocalized by confocal immunofluorescencecalculated from the experiments shown in Figure S4, with 0.5 mM, 1.0 mM, or
CA2: n = 28 (0.5 mM), 23 (1.0 mM), 25 (2.0 mM).
esenting store-independent Ca2+ influx (H) and internal Ca2+ store content (I) in
0.05 (Student’s t test).
d E).
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Figure 4. SPCA2 Interacts with Orai1 to Mediate Ca2+ Entry
(A) Confocal micrographs of immunofluorescence staining of endogenous SPCA2 in MCF-7 cells showing partial plasma membrane localization.
(B) Cell-surface biotinylation of endogenous SPCA2 and Orai1 in MCF-7 cells. T and B represent total lysate and biotinylated fraction, respectively.
(C) Coimmunoprecipitation of endogenous SPCA2 and Orai1 in MCF-7 cells.
(D) Coimmunoprecipitation of HA-SPCA with Orai1-Myc following expression in HEK293.
(E) Cell-surface biotinylation of HA-tagged SPCA1, SPCA2, or D379N SPCA2 expressed in HEK293.
(F) Basal Ca2+ in MCF-7 cells after knockdown of endogenous SPCA2 or Orai1. ControlKD, n = 47; SPCA2KD, n = 54; Orai1KD, n = 52. **p < 0.01 (Student’s t test).
(G) Normalized proliferation of MCF-7 cells with SPCA2 or Orai1 knockdown; n = 3.
(H) Immunoblot of ERK 1/2 phosphorylation and cyclin D1 expression in MCF-7 cells with SPCA2 or Orai1 knockdown.
(I) Normalized growth of MCF-7 cells with SPCA2 or Orai1 knockdown in soft agar; n = 3.
(J) Tumor incidence in nude mice injected with MCF-7 cells; controlKD, n = 10; SPCA2KD, n = 8, p = 0.007 (log-rank test); Orai1KD, n = 9, p = 0.045 (log-rank test).
Immunoblot (K) and normalized growth in soft agar (L) of MCF-10A cells with knockdown of Orai1 in control and cells overexpressing SPCA2. n = 3 in (L).
Error bars represent standard error (F) or standard deviation (G, I, and L).
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microscopy (Figure S5D). Unlike STIM (Yeromin et al., 2006),
interaction between SPCA2 and Orai1 was not affected by store
depletion with thapsigargin, consistent with a store-independent
regulation of Orai1 function (Figure S5E). Supporting this possi-
bility, neither WT STIM1 nor the constitutively active STIM1
mutant (D76A) (Huang et al., 2006; Liou et al., 2005) was in the
same protein complex as SPCA2 (Figure S5F). These findings
point to Orai1 as a likely candidate for mediating SPCA2-regu-
lated, store-independent Ca2+ influx in breast cancer cells.
To evaluate this possibility, we suppressed the expression of
endogenous Orai1 in MCF-7 cells: Orai1KD lowered basal Ca2+
to levels comparable to those seen upon depleting endogenous
SPCA2 (Figure 4F). In addition, Orai1KD in MCF-7 cells sup-
pressed cell proliferation (Figure 4G) and inhibited the RAS
pathway, as did SPCA2KD (Figure 4H and Figure S5G). Further-
more, Orai1KD suppressed colony formation in soft agar, to
a similar extent as SPCA2KD (Figure 4I), and tumor generation
in nude mice (Figure 4J). Simultaneous knockdown of both
Orai1 and SPCA2 did not confer additive phenotypes (Figures
S5H, S5J, and S5K). In MCF-10A cells overexpressing SPCA2,
cell transformation and elevation of basal Ca2+ level were
reversed by knockdown of Orai1, consistent with a role for
Orai1 downstream of SPCA2 (Figures 4K–4L and Figure S5L).
As expected for a store-independentmechanismofOrai1 activa-
tion, depletion of STIM1 (Figures S5M–S5O) or STIM2 (Figures
S5I–S5K), the upstream activators of Orai1 in SOCE signaling,
did not confer comparable phenotypes in MCF-7 cells. Taken
together, our data point to promotion of tumorigenic pathways
by SPCA2 in breast cancer cells, mediated by interaction with
Orai1.
Amino Terminus of SPCA2 Interacts with Orai1
To dissect themolecular determinants of the SPCA2-Orai1 inter-
action, we evaluated the efficiency of coimmunoprecipitation
between a series of SPCA chimeric proteins and Orai1. In each
case, the ability of a chimeric protein to coimmunoprecipitate
with Orai1 correlated with ability to elicit NFAT translocation,
suggesting that physical interaction between the two proteins
was required for Ca2+ signaling. Chimeras containing the
SPCA2 N terminus showed stronger binding with Orai1 and
more effective NFAT translocation (Figures 5A–5C).
Next, we examined physical interaction between Orai1 and
major intracellular soluble domains of SPCA2, including N and
C termini and the large intracellular loop, which contains the
iconic aspartate of P-type ATPases (D379). Of these, only the
N terminus was able to pull down Orai1 (Figure 5D). To further
map regions within the SPCA2 N terminus responsible for
binding to Orai1, we performed GST pull downs between Orai1
and a series of SPCA1 and SPCA2 fragments. The SPCA1
N terminus did not bind to Orai1, consistent with an absence
of functional interaction between SPCA1 and Orai1 (Figure 5E).
A region of 40 amino acids within the N terminus of SPCA2
was able to effectively interact with Orai1 (Figure 5E; construct
SPCA2N-8, aa 67–106). Surprisingly, this region was highly
conserved between the two isoforms, with 50% amino acid
identity (Figure S6A). We therefore conducted mutational
replacement of amino acids in the SPCA2 N terminus with the
equivalent residues in SPCA1 and identified four amino acidsthat together were critical for interaction between the SPCA2
N terminus and Orai1 (Figure 5F). Three-dimensional structure
of the SPCA2 N terminus, predicted by I-TASSER server (Wu
et al., 2007), suggested that Val71, Thr75, and Ser78 were
spatially clustered, whereas Val95 was on the remote side
(Figure 5G, Figures S6B and S6C, and Table S1).
Finally, we evaluated the effect of Orai1 expression on the
intracellular localization of N-terminal fragments of SPCA1 and
SPCA2 in HEK293 cells. When expressed alone, both fragments
were localized intracellularly, with the SPCA1 N-terminal frag-
ment diffusely distributed in the cytosol, and the SPCA2
N terminus concentrated in the perinuclear region. Although
the coexpression of Orai1 did not change localization of the
SPCA1 N terminus, there was a redistribution of the SPCA2
N terminus to the cell surface, providing additional evidence
that the N-terminal domain of SPCA2, but not SPCA1, interacts
physically with Orai1 (Figure 5H).
Cooperation of SPCA2 N and C Termini in Ca2+ Signaling
We further investigated the molecular mechanism of SPCA2-
activated Ca2+ signaling. We noticed that the isolated N terminus
of SPCA2 did not elicit NFAT translocation despite being
able to interact directly with Orai1, while the C terminus was
sufficient to induce NFAT translocation when it was linked to
two or more transmembrane domains and targeted to the
membrane (Figure 6A and Figures S7A and S7B). Surprisingly,
a similar membrane-anchored construct containing the SPCA1
C terminus was also able to activate constitutive Ca2+ signaling
even though full-length SPCA1 could not (Figure 6A). In addition,
both SPCA1 and SPCA2 membrane-anchored C-terminal
domains physically interacted with Orai1 (Figure S7C). We
hypothesized that access of the SPCA C terminus to Orai1
was blocked in the full-length proteins, and binding of the
SPCA2 N terminus to Orai1 led to exposure of the C terminus
and activation of downstream Ca2+ signaling. Analysis of
deletion and point mutants of the SPCA2 C terminus identified
essential functional residues including several positive charges
(lysines and arginines) and a putative PDZ binding domain (Fig-
ure 6A and Figure S7D), conserved between human, rat, and
mouse SPCA proteins (Figure S7E). We then measured intracel-
lular Ca2+ concentrations upon expression of SPCA2 C-terminal
constructs in HEK293 cells. Basal Ca2+ level was elevated
dramatically by expression of the SPCA2 C terminus but
remained the same as GST control when lysines (arginines)
were mutated or the putative PDZ domain was deleted
(Figure 6B). The N-terminal domain of SPCA2, but not SPCA1,
had a dominant-negative effect, dramatically inhibiting NFAT
translocation induced by full-length SPCA2 or the C terminus
(Figure 6C), whereas SOCE was not blocked by the SPCA2
N terminus or full-length with the C terminus deleted (SPCA2
D924–946) (Figure S7F). Importantly, expression of the mem-
brane-anchored SPCA2 C terminus in MCF-10A cells was able
to induce cell transformation, consistent with the fact that it
was identified to be the functional domain of SPCA2 and elicited
constitutive Ca2+ signaling (Figure 6D). STIM1 CRAC activation
domain (Park et al., 2009) showed a similar effect, supporting
the role of Ca2+ signaling in cell transformation (Figures S7G
and S7H).Cell 143, 84–98, October 1, 2010 ª2010 Elsevier Inc. 91
Figure 5. N-Terminal Domain of SPCA2 Interacts with Orai1
(A) Schematic of SPCA chimeras. N1 and C1 have the N and C termini of SPCA2 replaced by corresponding regions of SPCA1. N2 and C2 have N and C termini of
SPCA1 replaced by corresponding regions of SPCA2. ‘‘P’’ indicates the conserved aspartate that is transiently phosphorylated by ATP in the catalytic cycle. ‘‘L’’
represents intracellular loop.
(B) Interaction between Orai1 and SPCA chimeras was examined by coimmunoprecipitation in HEK293 cells.
(C) Quantification of NFAT nuclear translocation in HEK293 cells expressing SPCA chimeras described in (B). n = 3; error bars represent standard deviation.
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We next expressed GST fusions of various Orai1 domains
including N and C termini, extra- and intracellular loops
together with full-length SPCA2 or the N-terminal fragment of
SPCA2. Both N and C termini, but not the loops of Orai1,
were able to pull down both full-length and N terminus of
SPCA2, revealing that SPCA2 and Orai1 interacted within the
cytoplasm (Figures 6E and 6F). We then mapped subregions
of Orai1 N and C termini to further explore SPCA2 interaction
domains (Figure 6G). GST pull-down experiments identified
a fragment (aa 48–91) of the Orai1 N terminus that bound
SPCA2 with a higher affinity than the full-length N terminus.
Mutation L273S, previously shown to disrupt the coiled-coil
domain of the C terminus of Orai1 (Muik et al., 2008), severely
reduced the interaction with SPCA2 (Figure 6G). Taken
together, we propose a model for SPCA2 interaction with
Orai1 and activation of Ca2+ signaling. We suggest that the N
terminus of SPCA2 binds Orai1, resulting in a conformational
change and exposure of the C terminus, which can interact
with Orai1 either directly or together with other proteins to acti-
vate Ca2+ influx (Figure S7I).DISCUSSION
Role of SPCA2 and Orai1 in Breast Tumorigenicity
Our findings reveal a mechanism for activation of the so-called
SOCE channel Orai1 that is independent of ER and Golgi
Ca2+ stores and sensors. This store-independent mode of
endogenous Orai1 activation in breast cancer-derived MCF-7
cells underlies constitutive Ca2+ signaling, proliferation, and
anchorage-independent growth and implicates a hitherto unrec-
ognized role for Orai1 in breast tumorigenicity. We also identified
a role for SPCA2 in tumorigenicity and revealed a functional link
to RAS signaling. The RAS-ERK pathway regulates cell-cycle
progression and cell proliferation, and it is well known that
hyperactivation of the RAS gene family correlates with various
human cancers (Bos, 1989). GTP-exchange factors (GEFs) and
GTPase-activating proteins (GAPs) control activity of RAS by
regulating the balance of GTP binding and hydrolysis (Donovan
et al., 2002; Downward, 1996). Recent studies have suggested
that GEFs and GAPs can be regulated by different Ca2+ signals,
such as amplitude of the Ca2+ signals and frequency of Ca2+
oscillation (Cook and Lockyer, 2006). By monitoring activation
of ERK and expression of the downstream protein cyclin D1,
we revealed a correlation between SPCA2 and Orai1-mediated
increase of basal Ca2+ levels and constitutive activation of RAS
signaling in MCF-7 cells, placing the SPCA2-Orai1 pathway in
the RAS signaling network.(D) Interaction between the SPCA2 N terminus (N: aa 1–106), intracellular loop (L: a
down in HEK293 cells.
(E) Mapping of regions in SPCA1/2 that interact with Orai1. GST-SPCA1/2 N-term
tion with Orai1 was examined by GST pull-down. Sequence conservation betwee
senting identical, similar, and different amino acids, respectively, as defined by C
(F) Screening of SPCA2 N terminus for amino acids critical for the interaction wit
acids to the equivalent residues in SPCA1 N terminus.
(G) Predicted 3D structure of the SPCA2 N terminus with residues essential for i
(H) Localization of SPCA1/2 N termini, with or without coexpression of Orai1.Mechanism of Orai1-Mediated Ca2+ Signaling
Induced by SPCA2
It has been reported that STIM1 and Orai1 mediate CRAC
currents in endothelial cells, and knockdown of either elicits
cell-cycle arrest (Abdullaev et al., 2008). Another recent study
implicated a store-dependent role for Orai1 in cell migration of
the metastatic breast cancer line MDA-MB-231, based on
a requirement for STIM1 (Yang et al., 2009). We note that
SPCA2 expression is very low in MDA-MB-231 (data not shown),
consistent with a Ca2+ signaling mechanism distinct from the
store-independent pathway reported here. Although the impor-
tance of SOC signaling is well established, the store independent
Ca2+ signaling described in our study suggests that multiple
mechanisms may invoke Orai1 activation. Interaction between
SPCA2 and Orai1 was not affected by ER store depletion and
activation of SOC signaling, and SOCE was not inhibited by
expression of SPCA2, supporting that SPCA-induced signaling
may function independently of the SOC pathway and different
pools or fine subdomains of Orai1 are involved in the two
pathways.
ER-localized Ca2+ sensor STIM proteins, which regulate
SOCE, did not physically interact with SPCA2 or participate in
regulation of the SPCA2-Orai1 signaling pathway. In addition,
internal Ca2+ store content was not depleted by suppression or
overexpression of SPCA2. Thus, it remains to be determined
how the store-independent, Orai1-mediated mechanism of Ca2+
influx is regulated. One possibility is that signaling activity of
SPCA2 is regulated by its trafficking between Golgi and plasma
membrane. Interaction with Orai1 at the cell surface may be
dependent on a specific conformation of SPCA2, which could
be regulated by kinase-mediated phosphorylation, Ca2+ binding,
or changes in pH between extracellular and Golgi lumen.
Removal of a potential PDZ-bindingmotif in the last four residues
of the C-terminal tail of SPCA2 abolished Ca2+ signaling, sug-
gesting that interaction with scaffold proteins may be important
for activation of this signaling pathway.
Based on the function of a series of chimeras and mutant
proteins, we propose a model in which cooperation of N and
C termini of SPCA2 is required for Orai1-mediated Ca2+
signaling. Whereas the N terminus of SPCA2 binds strongly to
Orai1, the C terminus elicits activation of Ca2+ influx. Although
the Orai1-binding domain within the SPCA2 N terminus is highly
conserved with the corresponding region of SPCA1, no interac-
tion was detected between the SPCA1 N terminus and Orai1.
Replacement of four residues within the minimal Orai1-binding
domain of the SPCA2 N terminus (Val71, Thr75, Ser78, and
Val95) to the corresponding less hydrophobic or charged resi-
dues in SPCA1 abolished the interaction with Orai1.a 353–733), C terminus (C: aa 923–946), and Orai1 was examined by GST pull-
inal fragments were coexpressed with HA-Orai1 in HEK293 cells, and interac-
n SPCA1 and SPCA2 is shown on top, with black, gray, and white bars repre-
lustalW.
h Orai1 in HEK293 cells. Point mutations in SPCA2 N terminus convert amino
nteraction with Orai1 shown in red.
Cell 143, 84–98, October 1, 2010 ª2010 Elsevier Inc. 93
Figure 6. Cooperation of SPCA2 N- and C-Terminal Domains in Ca2+ Signaling
(A) SPCA2 C terminus was sufficient to activate Ca2+ signaling. Functions of deletion and point mutants of SPCA2 C-terminal domain were examined by NFAT
translocation assay in HEK293 cells. Full-length SPCA proteins were HA-tagged, and all C terminus fragments shown were GST-tagged; n = 3.
(B) Basal intracellular Ca2+ concentrations in HEK293 cells, with the expression of GST-tagged deletion and point mutants of the SPCA2 C-terminal domain
described in (A). From left to right, n = 49, 45, 46, 48, 40, 54, 59.
(C) Effects of N-terminal fragments of SPCA proteins on NFAT translocation induced by SPCA2 full-length or C-terminal fragment shown in (A). n = 3.
(D) Immunoblot and normalized cell growth in soft agar of MCF-10A cells transduced with vector, SPCA2, GST, and membrane-anchored SPCA2 C terminus
(GST-tagged); n = 3.
(E and F) Interaction between Orai1 N termini (N: aa 1–91), C termini (C: aa 255–301), intracellular loops (L1: aa 141–177), extracellular loops (L2: aa198-234), and
SPCA2 full-length or N terminus.
(G) Interaction between Orai1 full-length and subregions of N terminus (N: aa 1–91; N1: aa 1–47; N2: aa 48–91), C terminus (C: aa 255–301), C terminus mutation
(C-L273S), and SPCA2.
Error bars represent standard error (B) or standard deviation (A, C, and D).Interestingly, C-terminal constructs of both SPCA isoforms,
anchored to the membrane by a minimum of two transmem-
brane helices, were able to elicit Ca2+ influx and signaling.
Consistent with this, critical amino acids within the C terminus
were conserved in both isoforms from rat, mouse, and human.94 Cell 143, 84–98, October 1, 2010 ª2010 Elsevier Inc.Therefore, we propose a mechanism in which accessibility of
SPCA C termini is blocked in the full-length protein and binding
of the N terminus to Orai1 is required for functional availability
of the C terminus. Consistent with this hypothesis, we find that
expression of the soluble N-terminal domain from SPCA2, but
not SPCA1, has a dominant-negative effect in blocking activa-
tion of Ca2+ signaling. Long-range conformational interactions
between the N terminus and other cytosolic domains have
been noted in SPCA and other P-type pumps, aswell as changes
in accessibility of the C-terminal tail (Huster and Lutsenko, 2003;
Lecchi et al., 2005; Wei et al., 1999). Recently, Garside et al.
(2010) identified an alternative transcript of SPCA2, encoding
an 20 kDa membrane-anchored C-terminal fragment, in
tissues including brain, testes, salivary glands, and pancreas.
Expression of this transcript was under the control of MIST1,
a basic helix-loop-helix transcription factor, and appeared to
be independent of the full-length transcript. This suggests the
intriguing possibility that a C-terminal fragment of SPCA2 may
elicit Ca2+ signaling independent of the full-length transporter.
Physiological and Pathophysiological Perspectives
of SPCA2-Induced Ca2+ Signaling
The conventional role of ATP-powered Ca2+ pumps is to scav-
enge and extrude cytoplasmic Ca2+ in order to terminate a signal,
and as a prerequisite for additional signaling events. Unexpect-
edly, high levels of expression of the Ca2+ efflux pump SPCA2
increased rather than lowered basal cytoplasmic Ca2+ levels,
and conversely, attenuation of SPCA2 expression was accom-
panied by a decrease in basal Ca2+. We speculate that this
unconventional mechanism may be physiologically important
in eliciting high rates of transcellular Ca2+ flux during lactation
(Lee et al., 2006) and in other Ca2+-secreting tissues, including
salivary glands and intestinal epithelia, where SPCA2 is
expressed at high levels. Total calcium concentration in milk
can reach up to 100 mM, five to six orders of magnitude greater
than typical cytoplasmic concentrations (0.1 mM). Thus,
there must be energy-dependent transport processes for
effective transcellular movement of Ca2+ from blood into milk.
In mammary gland, a 30-fold transcriptional increase in the
plasmamembraneCa2+ pump isoform, PMCA2, is accompanied
by apical efflux of Ca2+ into milk (Reinhardt et al., 2004).
Compared to modest changes in SPCA1 levels, SPCA2 was
found to be upregulated during pregnancy (8-fold) and dramat-
ically upon lactation (35-fold on day 1). Furthermore, SPCA2
expression was restricted to the lumenal cells of lactating glands
(Faddy et al., 2008). Our findings raise the possibility that SPCA2
traffics to the basolateral membrane where it can interact with
Ca2+ channels to elicit Ca2+ influx and promote transcellular
Ca2+ transport.
The unusual role of SPCA2 in activation of Ca2+ influx super-
sedes its ATP-dependent Ca2+ sequestering activity and may
be a raison d’etre for its redundant expression along with
SPCA1 in mammals and higher vertebrates. It is noteworthy
that in lower eukaryotes (yeast, worm, fly) and vertebrates (fish)
there is only a single ubiquitously expressed SPCA protein,
which functions in transporting Ca2+ and Mn2+ into the secretory
pathway. The advent of the SPCA2 gene in higher eukaryotes
including frog,mouse, rat, and humanmay correlate with a newly
required role in Ca2+ signaling. At the molecular level, a longer
and divergent N terminus appears to have endowed SPCA2
with the ability to interact with unique partners, and discrete
cell- and tissue-specific distribution would appear to regulate
its function. Whereas in lactation, an exquisitely orchestrateddevelopmental program ensures a coordinated regulation of
Ca2+ pumps, channels, receptors, and buffers, there is emerging
appreciation for a pronounced dysregulation of these processes
in breast-derived tumor cells. For example, an aberrant switch in
heterotrimeric G protein preference by the calcium sensing
receptor, CaSR, in breast cancer cells leads to stimulation of
cAMP signaling and increased secretion of PTHrP, which in
turn is believed to contribute to a ‘‘vicious cycle’’ or feedforward
loop of bonemetastasis and osteolysis (Mamillapalli et al., 2008).
Thus, the upregulation of SPCA2 in the altered signaling environ-
ment of tumor cells may result in constitutive Ca2+ signaling and
cell growth. Inappropriate secretion of Ca2+ from these cells, in
the absence of calcium buffers, could lead to microcalcifications
that are diagnostic of breast cancer. Finally, the separation of
signaling function from transport activity in SPCA2, evidenced
by our findings, is highly unusual in pumps. An extreme case is
SUR1, an ABC transporter that lacks known transport activity
but is essential for conferring ATP sensitivity to KATP channels
in insulin-secreting pancreatic b cells (Aittoniemi et al., 2009).
In summary, we identified a store-independent SPCA2-Orai1
signaling pathway. Upregulation of SPCA2 led to constitutively
active Ca2+ signaling and correlated with oncogenic activity in
breast cancer. Both SPCA2 and Orai1 emerge as druggable
targets of therapeutic potential in the treatment of some breast
cancer subtypes.
EXPERIMENTAL PROCEDURES
Materials and additional experimental procedures are described in the Supple-
mental Information.
SPCA2 Analysis in Human Breast Tumors
A gene expression dataset consisting of the microarray profiles of 295 primary
human breast tumors (van de Vijver et al., 2002) was obtained from Rosetta
Inpharmatics (Seattle, WA, USA). Tumors were assigned to transcriptional
subtypes based on their gene expression profiles (Lumenal A [n = 88], Lumenal
B [n = 81], Normal-like [n = 31], Basal-like [n = 46], and ERBB2+ [n = 49]) as
described (Chang et al., 2005). One probe on the array (annotated as
KIAA0703) corresponded to SPCA2. Tumors were grouped by transcriptional
subtype and analyzed for SPCA2 expression. Statistical significance
between groups was assessed by comparing medians using the Kruskall-
Wallis test followed by Dunn’s Multiple Comparison Test (Prism version 5,
Graphpad Inc.).
NFAT Translocation Assay
Monitoring of nuclear translocation of NFAT was performed 24 hr post-trans-
fection in HEK293 cells. Fresh medium was added 2 hr before the start of the
experiment. Localization of NFAT-GFP and NFAT-mCherry in cells was exam-
ined by fluorescentmicroscopy. 100–300 cells weremanually counted on each
coverslip, 3 wells for each condition, and the fraction of cells with nuclear NFAT
was calculated. Where indicated, 2 mM thapsigargin was added for 30 min,
10 mM miconazole was used for 1 hr, and 50 mM 2-APB was used for 1 hr.
Calcium Imaging and Mn2+ Quench
Cells were loaded with Fura-2 AM at 1 mg/ml in calcium recording buffer
(126 mM NaCl, 2 mM MgCl2, 4.5 mM KCl, 10 mM Glucose, 20 mM HEPES
pH 7.4, 2 mM CaCl2; no CaCl2 was added for the 0 Ca
2+ buffer) for 30 min
at room temperature (RT). After loading, cells were rinsed in the same calcium
recording buffer without Fura-2 for 20 min. Cells were excited at 340 nm and
380 nm, and Fura AM emission at 505 nm was monitored. Intracellular Ca2+
concentration was calculated based on the ratio of 340/380 nm. For Mn2+
quench of Fura-2 fluorescence, 0.5 mM of Mn2+ was added to nominally
Ca2+-free buffer. Cells were excited at 360 nm, the isosbestic point ofCell 143, 84–98, October 1, 2010 ª2010 Elsevier Inc. 95
Fura-2, and emission at 505 nm was monitored. The average fluorescence of
10 time points (50 s) before Mn2+ addition was set as 100%.
Construction, Production, and Infection of Lentiviruses
and Retroviruses
Replication-incompetent lentivirus was used to package shRNA for knock-
down in MCF-7 cells and HEK293 cells. Cells were incubated with viruses
for 48 hr and selected with puromycin (2-4 mg/ml).
Retroviral gene transfer and expression system (Clontech, Mountain View,
CA, USA) was used for stable expression of SPCA2 in MCF-10 cells. SPCA2
gene was cloned into pLXRN vector to package retroviruses. Viruses were
collected 48 hr after transfection and added to MCF-10A cells. Cells
were treated with G418 (400 mg/ml) after 48 hr infection and selected cells
were used to assay proliferation and colony formation in soft agar.
Cell Proliferation Assay
Proliferation was monitored using a Celltiter 96 Aqueous One Solution cell
proliferation assay kit (Promega, Madison, WI, USA) according to manufac-
turer’s instructions. Briefly, 0.5–1 3 104 cells were plated into a 96-well plate.
After every 24 hr, 20 ml of Celltiter 96 AqueousOne Solution reagent was added
to each well and incubated for 2 hr at 37C, 5% CO2. The absorbance at
490 nM was recorded using a 96-well plate reader.
Colony Formation in Soft Agar
Colony formation in soft agar assay was performed using a CytoSelect
96-well cell transformation assay kit (Cell Biolabs, San Diego, CA, USA). In
a 96-well plate, 0.5–1 3 104 cells were resuspended in DMEM containing
0.4% agar and 10% FBS and layered onto a base agar consisting of
DMEMwith 0.6% agar and 10% FBS. Following solidification, growth medium
was added on to the cell agar layer. One to two weeks later, colonies were
imaged under the microscope, the agar layer was solubilized, and cells
were lysed and quantified with CyQuant GR dye. The plate was read in a
FLUOstar Optima plate reader (BMG Labtechnologies) using a 485/520 nm
filter set.
Tumor Formation in Nude Mice
Female 4- to 6-week-old athymic nude mice (NCI) were received by the animal
facility personnel and acclimated at the facility for 2 weeks. Estrogen pellets
(SE-121, 0.72 mg/pellet, 60 days release) were obtained from Innovative
Research of America. For each animal, a pellet was implanted into the back
of the neck through a 1 cm cut and the wound was closed by a wound clip.
After 3 days of implantation, the animals were ready to be injected with cells.
MCF-7 cells transduced with control or SPCA2 shRNA or Orai1 shRNA were
trypsinized and diluted to 1.5–3 3 107 cells per ml in PBS. 3 3 106 cells per
animal were injected subcutaneously into the flank of each of 6–10 mice.
The incidence of tumor formation was recorded in each animal once per
week, starting 14–18 days after injection. Animal care was in accordance
with institutional guidelines. One animal with subsequent tumor necrosis
was euthanized, others were sacrificed after 10 weeks of observation.
Immunofluorescence
Cultured HEK293 and MCF-7 cells on coverslips were pre-extracted with
PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, and 2 mM
MgCl2, pH 6.8) containing 0.025% saponin for 2 min, then washed twice for
2 min with PHEM buffer containing 0.025% saponin and 8% sucrose. The cells
were fixedwith a solution of 4%PFA and 8%sucrose in PBS for 30min at room
temperature and blocked with a solution of 1% BSA and 0.025% saponin in
PBS for 1 hr. Primary antibodies were diluted 1:500 in 1% BSA and incubated
with the cells for 1 hr. Alexa-Fluor 488 goat anti-rabbit IgG (Invitrogen) and
Alexa-Fluor 568 goat anti-mouse IgG were used at a 1:1000 dilution for
30 min. Cells were mounted onto slides using Dako Fluorescent Mounting
Medium. Slides were imaged on a Zeiss LSM510-Meta confocal microscope.
In Figure 4A, anti-SPCA2 was used. In Figure 5H, anti-SPCA2, anti-SPCA1,
and anti-HA were used to detect SPCA2N, SPCA1N, and HA-Orai1. In
Figure S3C, anti-Myc, anti-SPCA1, and anti-Golgi97 were used to detect
Myc-STIM1, HA-SPCA1, and Golgi 97. In Figure S5D, anti-SPCA2 and anti-96 Cell 143, 84–98, October 1, 2010 ª2010 Elsevier Inc.HA were used to detect Myc-SPCA2 and HA-Orai1. In Figure S7B, anti-GST
and anti-HA were used to detect GST-SPCA2C and HA-Orai1.
Coimmunoprecipitation and GST Pull-Down
Coimmunoprecipitation (co-IP) and GST pull-down assay in HEK293 cells
were performed 24 hr after transfection. Co-IP in MCF-7 cells for endogenous
proteins was performed 24–48 hr after seeding cells. Cells were lysed in lysis
buffer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM Na3EDTA, 1 mM EGTA,
5 mM Na4P2O7, 1 mM Na3VO4, 10 mM NaF, supplemented with 1% Triton
X-100 and protease inhibitor cocktail [Roche]). 1/10 of the lysate was saved
as ‘‘input.’’ For co-IP, cell lysate was incubated 1 hr with GammaBind Plus
Sepharose (GE Healthcare, Waukesha, WI, USA) for preclearance and 1–4 hr
with antibodies (anti-Myc or anti-SPCA2) at 4C. GammaBind beads were
added and incubated for 1 hr at 4C. For GST pull-down assay, cell lysate
was incubated 2 hr with glutathione Sepharose 4B. Beads were washed using
lysis buffer supplemented with 1% Triton X-100 before SDS-PAGE and immu-
noblotting. 1/2 of the ‘‘input’’ and 1/2 to 1/8 of the co-IP/pull-down fraction
were loaded to SDS-PAGE gels. To co-IP cell-surface Orai1 with SPCA2, cells
were biotin-labeled, lysed, and immunoprecipitated using anti-SPCA2 anti-
body. The proteins on the GammaBind beads were eluted with lysis buffer
containing 1% SDS and incubated with neutravidin resin overnight at RT.
Beads were washed in the same buffer. Only the portion of Orai1 that bound
to SPCA2 at the cell surface was detected using SDS-PAGE and immunoblot-
ting. 1/2 of the ‘‘input’’ and 1/2 of the biotinylated fraction were loaded to SDS-
PAGE gels.
Functional Complementation in Yeast
Yeast growth assays were performed as described before (Xiang et al., 2005).
The yeast strain K616 (pmr1Dpmc1Dcnb1D) was used as host for plasmids
expressing SPCA2. Freshly grown cells were inoculated into each well of
96-well plates at 0.05 optical density (OD) 600 nm. Plates were incubated over-
night at 30C and resuspended by agitation, and OD600 nm was measured
using a FLUOstar Optima plate reader.
Three-Dimensional Structure Prediction
I-TASSER method was used to predict 3D protein structure from the primary
amino acid sequence of the SPCA2 N terminus. I-TASSER was ranked as
the No.1 server in recent CASP7 and CASP8 experiments (Critical Assessment
of Protein Structure Prediction).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at doi:10.1016/
j.cell.2010.08.040.
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